What is WisdomTree Japan Equity UCITS ETF (DXJG)?
WisdomTree Japan Equity UCITS ETF is an exchange-traded fund designed to provide exposure to the Japanese equity market. The fund seeks to track the performance of a specific index that represents Japanese companies, typically focusing on dividend-paying firms or a broad market segment. It is structured as a UCITS (Undertakings for Collective Investment in Transferable Securities) fund, which adheres to regulatory standards within the European Union, ensuring investor protection and transparency. The ETF offers investors a means to gain diversified exposure to Japan's economy through publicly traded equities, encompassing various sectors such as technology, manufacturing, and consumer goods. It is managed by WisdomTree, a global asset management company specializing in exchange-traded products. The fund's investment approach often emphasizes factors like dividend yield or market capitalization, depending on the underlying index methodology. As a passive investment vehicle, it aims to replicate the performance of its benchmark index, providing an accessible option for investors seeking to include Japanese equities in their portfolios.
WisdomTree Japan Equity UCITS ETF Stock Price Today: Live Overview
The price today is shaped by intraday activity, with KraneShares ICBCUBS S&P China 500 UCITS ETF at £29.620. It has traded within the range of £28.88 to £29.81, showing a daily change of -1.5426%.
FAQ: WisdomTree Japan Equity UCITS ETF (DXJG)
What is the current price of DXJG stock?
The last price is £29.620.
Does DXJG pay dividends?
Dividends are distributed by this ETF via cash distributions (if applicable).
Does DXJG have a formal corporate presence or regional headquarters in the UAE?
The ETF does not have a registered office or subsidiary in the UAE but is accessible through local partners.
What is DXJG best known for?
This ETF is most famous for providing exposure to Japanese equity markets.
What assets are typically shown together with DXJG?
Commonly shown alongside DXJG: Zai Lab Limited, Royalty Pharma plc, GAM
Latest shares articles



